cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Fate Therapeutics Inc
14 own
12 watching
Current Price
$0
$-0.35
(-6.4%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
537.1M
52-Week High
52-Week High
37.13
52-Week Low
52-Week Low
4.02
Average Volume
Average Volume
0.38M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization537.1M
icon52-Week High37.13
icon52-Week Low4.02
iconAverage Volume0.38M
iconDividend Yield--
iconP/E Ratio--
What does the Fate Therapeutics Inc do?
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its immuno-oncology product candidates include FATE-NK100, a natural killer (NK) cell cancer immunotherapy that consists of adaptive memory NK cells; engineered hnCD16 induced pluripotent stem cells (iPSC)-derived natural killer cell therapy candidates for hematologic/solid tumors; and engineered chimeric antigen receptor iPSC-derived T cell therapy product candidates for hematologic/solid tumors. The company's immuno-regulation product candidates comprise ProTmune, an investigational programmed cellular immunotherapy for use as a next-generation allogeneic hematopoietic cell transplantation cell graft; and ToleraCyte for the treatment of autoimmune and inflammatory diseases; engineered iPSC-derived CD34+ cell therapy for immune disorders. Fate Therapeutics, Inc. has a research collaboration and license agreement with Memorial Sloan Kettering Cancer Center to develop off-the-shelf T-cell immunotherapies; and strategic research collaboration and license agreement with Juno Therapeutics, Inc. to identify small molecule modulators that enhance the function of T cells. Fate Therapeutics, Inc. was founded in 2007 and is headquartered in San Diego, California.
Read More
How much money does Fate Therapeutics Inc make?
News & Events about Fate Therapeutics Inc.
Benzinga
1month ago
read more...
Globe Newswire
1month ago
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (NASDAQ: CRBU) Johnson Fistel, LLP is investigating potential claims on behalf of Caribou Biosciences, Inc. ("Caribou" or the "Company") (NASDAQ: CRBU) against certain of its officers and directors. If you are a current, long-term...
Zolmax
2 months ago
StockNews.com lowered shares of Fate Therapeutics (NASDAQ:FATE Get Rating) from a hold rating to a sell rating in a research note released on Tuesday . FATE has been the subject of several other research reports. Bank of America cut Fate Therapeutics from a buy rating to an underperform rating in a ...
Globe Newswire
2 months ago
NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- Sotera Health Co. (NASDAQ: SHC) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Companys made false and misleading representations concerning ...
Ticker Report
2 months ago
Shares of Fate Therapeutics, Inc. (NASDAQ:FATE Get Rating) have been given a consensus rating of Hold by the twenty-three analysts that are currently covering the firm, Marketbeat reports. Two research analysts have rated the stock with a sell rating, fourteen have assigned a ...
Frequently Asked Questions
Frequently Asked Questions
What is Fate Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Fate Therapeutics Inc shares?
plus_minus_icon
How can I buy Fate Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Fate Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Fate Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Fate Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Fate Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Fate Therapeutics Inc?
plus_minus_icon
What percentage is Fate Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Fate Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$-0.35
(-6.4%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00